CLINICAL_TRIALS
trial_result
· 2022-01-04
Clinical Trial Update: Clinical Follow-up of Anti-Carbamylated Antibody Status in Rheumatoid Arthritis
Summary
A completed clinical trial follow-up study evaluating anti-carbamylated antibody status in rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Universidad Autonoma de Nuevo Leon | Conditions: RheumatoId Arthritis | Status: COMPLETED | Results posted: 2022-01-04